Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03209869
Title Treatment of Relapsed or Refractory Neuroblastoma With Expanded Haploidentical NK Cells and Hu14.18-IL2
Recruitment Suspended
Gender both
Phase Phase I
Variant Requirements No
Sponsors University of Wisconsin, Madison
Indications

neuroblastoma

Therapies

hu14.18-IL2

Age Groups: adult | child
Covered Countries USA


No variant requirements are available.